Cargando…

Estimating prevalence of early symptomatic Alzheimer's disease in the United States

INTRODUCTION: Understanding the prevalence of treatment‐eligible Alzheimer's disease (AD) is crucial for policy planning. METHODS: We used a comprehensive literature review and population cascade approach to estimate the number of amyloid‐positive, clinically diagnosed patients with mild cognit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Spargo, Drew, Zur, Richard, Lin, Pei‐Jung, Synnott, Patricia, Klein, Eric, Hartry, Ann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682565/ https://www.ncbi.nlm.nih.gov/pubmed/38034853 http://dx.doi.org/10.1002/dad2.12497

Ejemplares similares

Using electronic health records to estimate the prevalence of agitation in Alzheimer disease/dementia
por: Halpern, Rachel, et al.
Publicado: (2018)

Treatment patterns and burden of behavioral disturbances in patients with dementia in the United States: a claims database analysis
por: Aigbogun, Myrlene Sanon, et al.
Publicado: (2019)

Lanabecestat: Neuroimaging results in early symptomatic Alzheimer's disease
por: Zimmer, Jennifer A., et al.
Publicado: (2021)

Estimating eviction prevalence across the United States
por: Gromis, Ashley, et al.
Publicado: (2022)

Estimated prevalence of undiagnosed atrial fibrillation in the United States
por: Turakhia, Mintu P., et al.
Publicado: (2018)

Estimation of dementia prevalence at the local level in the United States
por: Bennett, Erin E., et al.
Publicado: (2021)

Estimating the Prevalence of Opioid Diversion by “Doctor Shoppers” in the United States
por: McDonald, Douglas C., et al.
Publicado: (2013)

Real-World Use of Symptomatic Treatments in Early Alzheimer’s Disease
por: Garcia, Maria João, et al.
Publicado: (2023)

A new way to estimate neurologic disease prevalence in the United States: Illustrated with MS
por: Nelson, Lorene M., et al.
Publicado: (2019)

Estimating the early death toll of COVID-19 in the United States
por: Weinberger, Daniel M., et al.
Publicado: (2020)

Contemporary prevalence estimates of undiagnosed and diagnosed atrial fibrillation in the United States
por: Turakhia, Mintu P., et al.
Publicado: (2023)

GEOGRAPHIC DISPARITIES IN COUNTY-LEVEL PREVALENCE OF ALZHEIMER’S DISEASE ACROSS THE UNITED STATES
por: Fowler, Mackenzie E, et al.
Publicado: (2019)

Geographic Disparities in County-Level Prevalence of Alzheimer’s Disease Across the United States
por: Fowler, Mackenzie, et al.
Publicado: (2020)

Early Estimates of Seasonal Influenza Vaccine Effectiveness — United States, January 2015
por: Flannery, Brendan, et al.
Publicado: (2015)

The prevalence of MS in the United States: A population-based estimate using health claims data
por: Wallin, Mitchell T., et al.
Publicado: (2019)

The conceptual relevance of assessment measures in patients with mild/mild-moderate Alzheimer's disease
por: Hartry, Ann, et al.
Publicado: (2018)

A modelling approach to estimate the prevalence of treatment-resistant schizophrenia in the United States
por: Mørup, Michael Frank, et al.
Publicado: (2020)

Updated Estimates and Mapping for Prevalence of Chagas Disease among Adults, United States
por: Irish, Amanda, et al.
Publicado: (2022)

Sources of variation in estimates of Duchenne and Becker muscular dystrophy prevalence in the United States
por: Whitehead, Nedra, et al.
Publicado: (2023)

Estimating the number of symptomatic SARS-CoV-2 infections among vaccinated individuals in the United States—January–July, 2021
por: Kugeler, Kiersten J., et al.
Publicado: (2022)

Cost-effectiveness of Drugs to Treat Relapsed/Refractory Multiple Myeloma in the United States
por: Carlson, Josh J., et al.
Publicado: (2018)

Early Estimates of Seasonal Influenza Vaccine Effectiveness — United States, January 2013
por: Jackson, Lisa, et al.
Publicado: (2013)

Quantification of white matter cellularity and damage in preclinical and early symptomatic Alzheimer's disease
por: Wang, Qing, et al.
Publicado: (2019)

Hyperhidrosis: an update on prevalence and severity in the United States
por: Doolittle, James, et al.
Publicado: (2016)

Institutionalization risk and costs associated with agitation in Alzheimer's disease
por: Cloutier, Martin, et al.
Publicado: (2019)

Data supporting updating estimates of the prevalence of chronic hepatitis B and C in the United States
por: Gish, Robert G., et al.
Publicado: (2015)

Simple Estimates for Local Prevalence of Latent Tuberculosis Infection, United States, 2011–2015
por: Haddad, Maryam B., et al.
Publicado: (2018)

Factoring Prior Treatment into Tuberculosis Infection Prevalence Estimates, United States, 2011–2012
por: Vonnahme, Laura A., et al.
Publicado: (2019)

Population-Based Estimates for the Prevalence of Multiple Sclerosis in the United States by Race, Ethnicity, Age, Sex, and Geographic Region
por: Hittle, Michael, et al.
Publicado: (2023)

Estimating the Impact of Newly Arrived Foreign-Born Persons on Tuberculosis in the United States
por: Liu, Yecai, et al.
Publicado: (2012)

Six psychotropics for pre-symptomatic & early Alzheimer's (MCI), Parkinson's, and Huntington's disease modification
por: Lauterbach, Edward C.
Publicado: (2016)

Prevalence of Prostate Cancer Clinical States and Mortality in the United States: Estimates Using a Dynamic Progression Model
por: Scher, Howard I., et al.
Publicado: (2015)

Using influenza surveillance networks to estimate state-specific prevalence of SARS-CoV-2 in the United States
por: Silverman, Justin D., et al.
Publicado: (2020)

HIV Trends in the United States: Diagnoses and Estimated Incidence
por: Hall, H Irene, et al.
Publicado: (2017)

Wikipedia Usage Estimates Prevalence of Influenza-Like Illness in the United States in Near Real-Time
por: McIver, David J., et al.
Publicado: (2014)

Indirect estimation of the prevalence of spinal muscular atrophy Type I, II, and III in the United States
por: Lally, Cathy, et al.
Publicado: (2017)

Caring for Older Patients With Cancer: Estimates of the Prevalence, Burden, and Unmet Needs of Caregivers in the United States
por: Kent, Erin
Publicado: (2020)

Prepandemic Prevalence Estimates of Fatty Liver Disease and Fibrosis Defined by Liver Elastography in the United States
por: Unalp-Arida, Aynur, et al.
Publicado: (2022)

The Impact of Delayed Symptomatic Treatment Implementation in the Intensive Care Unit
por: Meng, Lesley, et al.
Publicado: (2021)

Cancer prevalence in the United Kingdom: estimates for 2008
por: Maddams, J, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_tiann0mcmc6da7cs29ft0l8ro9